Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil
- 1 September 1988
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 13 (1) , 41-46
- https://doi.org/10.1016/0167-8140(88)90296-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Silent Myocardial Ischemia During Daily Activities: Studies in Asymptomatic Patients and Those with Various Forms of AnginaCardiology Clinics, 1986
- Cardiac Toxicity of 5-Fluorouracil Report of a Case of Spontaneous AnginaTumori Journal, 1986
- Paroxysmal Supraventricular Tachycardia during Treatment with Cisplatin and Etoposide CombinationOncology, 1985
- Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatinCancer, 1985
- Ischemic Cardiopathy from CIS-Diamminedichloroplatinum (CDDP)Tumori Journal, 1984
- Coronary insufficiency and 5-fluorouracil therapy: A case report, review, and suggestion regarding mechanismCleveland Clinic Journal of Medicine, 1983
- Cardiac Toxicity of 5-Fluorouracil: A Study on 1083 PatientsTumori Journal, 1982
- Oesophageal squamous cell carcinoma: II. A critical review of radiotherapyBritish Journal of Surgery, 1980
- Fluorouracil cardiotoxicity.BMJ, 1978
- 5-FLUOROURACIL AND ANGINAThe Lancet, 1975